ERBB2 and heart failure: These compounds may be mainly responsible for cardiac dysfunction, eventually leading to overt heart failure if associated with concomitant cardiotoxic therapies (e.g. Human Epidermal Growth Factor Receptor 2, HER2 inhibitors).